Formation and effects of leukotriene B4 in human lymphocytes.
Incubation of human tonsillar B lymphocytes or peripheral blood T lymphocytes with leukotriene (LT) A4 led to the formation of LTB4. Stimulation of these cells with ionophore A23187 did not lead to the synthesis of detectable amounts of leukotrienes. Formation of LTB4 was observed in several monoclonal B- and T-cell lines after incubation with LTA4, but not after stimulation with ionophore A23187. The Burkitt lymphoma cell line Raji was found to possess higher LTA4-hydrolase activity than normal lymphocytes. The expression of the LTA4-hydrolase gene but not the 5-lipoxygenase gene was demonstrated on the transcriptional level in Northern blots and on the translational level by Western blots. Stimulation of human monocytes with ionophore A23187 resulted in the release of LTA4. Coincubations of transformed lymphocytes and monocytes stimulated with ionophore A23187 produced increased amounts of LTB4 as compared with monocytes alone. LTB4 influence on lymphocyte activation was studied and CD23 expression was used as a marker. The expression of this antigen was enhanced on resting B lymphocytes in synergy with B-cell growth-promoting factors. LTB4 also augmented DNA synthesis, cell replication and IgG secretion. These results indicate that extracellular LTA4, released from activated monocytes, is converted by lymphocytes into LTB4 which might cause activation and differentiation of B lymphocytes.
Odlander
B
B
Dept. of Physiological Chemistry, Karolinska Institute, Stockholm, Sweden.
Jakobsson
P J
PJ
Medina
J F
JF
Rådmark
O
O
Yamaoka
K A
KA
Rosén
A
A
Claesson
H E
HE
D015703:Antigens, CD; D001402:B-Lymphocytes / Q000187:drug effects; D015152:Blotting, Northern; D015153:Blotting, Western; D000001:Calcimycin / Q000494:pharmacology; D002455:Cell Division; D002470:Cell Survival; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007136:Immunoglobulins / Q000096:biosynthesis; D017572:Leukotriene A4; D007975:Leukotriene B4 / Q000096:biosynthesis* / Q000502:physiology; D015289:Leukotrienes / Q000378:metabolism / Q000494:pharmacology; D008214:Lymphocytes / Q000378:metabolism*; D009000:Monocytes / Q000187:drug effects; D050378:T-Lymphocytes, Regulatory / Q000502:physiology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D007074:Immunoglobulin G; D007136:Immunoglobulins; D017572:Leukotriene A4; D015289:Leukotrienes; D014316:Tritium; D007975:Leukotriene B4; D000001:Calcimycin; D013936:Thymidine